Originally published by State House News Service on June 1, 2022
Most biopharmaceutical companies in Massachusetts expect to grow their workforces over the next year, but many have also had a hard time filling open positions, according to a new industry report.
The Massachusetts Biotechnology Council previously projected that the industry could require up to 40,000 new workers by 2024, and an analysis BW Research Partnership conducted for MassBio calls for the field to “re-think the current workforce development pipeline,” by prioritizing regionalization and diversity.
“Given that employers project to see growth across several different entry- and non-entry-level positions over the next couple years as well as the significant hiring difficulties attributed to a small applicant pool and lack of experienced or qualified applicants, the life sciences industry will require significant workforce development support mechanisms from the state, educational institutions, and other workforce development stakeholders,” reads the report, released Wednesday.